Myocardial Revascularization Surgery: One or Two Internal-Thoracic-Artery Grafts?

Myocardial Revascularization SurgeryThe use of both internal thoracic (mammary) arteries for myocardial revascularization surgery might improve long-term outcomes, compared with the use of a single internal thoracic artery.

 

Patients scheduled for myocardial revascularization surgery (only multivessel procedures; combined valve procedures were excluded) were randomized to receive a single internal-thoracic-artery graft (internal thoracic artery for the anterior descending artery, other vessels with grafts from veins or the radial artery) or two internal-thoracic-artery grafts (other vessels with grafts from veins or the radial artery) in 28 cardiac surgical centers in 7 countries.

 

The primary endpoint was all-cause death at 10 years, and the secondary endpoint was a composite of all-cause death, acute myocardial infarction, or stroke. An interim analysis was prespecified at 5 years of follow-up and is reported in this summary.

 

A total of 3102 patients were enrolled; 1554 were randomized to receive a single internal-thoracic-artery graft and 1548 to receive a double internal-thoracic-artery graft.

 

At 5 years of follow-up, the mortality rate was 8.7% for patients in the double internal-thoracic-artery graft group and 8.4% for those in the single internal-thoracic-artery graft group (hazard ratio [HR]: 1.04; 95% confidence interval [CI]: 0.81 to 1.32; p = 0.77). The rate of the composite endpoint of all-cause death, infarction, and stroke was 12.2% vs. 12.7%, respectively (HR: 0.96; 95% CI: 0.79 to 1.17; p = 0.69).

 

Differences were indeed observed regarding the risk of sternal wound infection, which was higher among those receiving a double internal-thoracic-artery graft (3.5% vs. 1.9%; p = 0.005), and the need for sternal reconstruction (1.9% vs. 0.6%; p = 0.002).

 

Conclusion

Among patients undergoing myocardial revascularization surgery, there were no benefits at 5 years for those receiving double internal-thoracic-artery grafts when compared with those in which only the left internal thoracic artery was used. Sternal wound infections and the need for sternal reconstruction were significantly more frequent in patients receiving double internal-thoracic-artery grafts. Ten-year follow-up is ongoing, and benefits are yet to be seen.

 

Original title: Randomized Trial of Bilateral Versus Single Internal-Thoracic-Artery Grafts.

Reference: David P. Taggart et al. N Engl J Med. 2016 Nov 14. [Epub ahead of print].


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...